IL108369A - Pharmaceuticals for increasing the susceptibility of malignant malignancies containing diarylalkyl piperidines - Google Patents
Pharmaceuticals for increasing the susceptibility of malignant malignancies containing diarylalkyl piperidinesInfo
- Publication number
- IL108369A IL108369A IL10836994A IL10836994A IL108369A IL 108369 A IL108369 A IL 108369A IL 10836994 A IL10836994 A IL 10836994A IL 10836994 A IL10836994 A IL 10836994A IL 108369 A IL108369 A IL 108369A
- Authority
- IL
- Israel
- Prior art keywords
- tumors
- hydrogen
- drug
- composition according
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
- C07D211/16—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with acylated ring nitrogen atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US656993A | 1993-01-21 | 1993-01-21 |
Publications (2)
Publication Number | Publication Date |
---|---|
IL108369A0 IL108369A0 (en) | 1994-04-12 |
IL108369A true IL108369A (en) | 1999-08-17 |
Family
ID=21721516
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL10836994A IL108369A (en) | 1993-01-21 | 1994-01-19 | Pharmaceuticals for increasing the susceptibility of malignant malignancies containing diarylalkyl piperidines |
Country Status (20)
Country | Link |
---|---|
US (1) | US5648365A (zh) |
EP (1) | EP0680470B1 (zh) |
JP (1) | JP3398748B2 (zh) |
KR (1) | KR100377280B1 (zh) |
AT (1) | ATE150748T1 (zh) |
AU (1) | AU679723B2 (zh) |
CA (1) | CA2152794C (zh) |
DE (1) | DE69309310T2 (zh) |
DK (1) | DK0680470T3 (zh) |
ES (1) | ES2102830T3 (zh) |
FI (1) | FI112474B (zh) |
GR (1) | GR3023188T3 (zh) |
HU (1) | HUT72078A (zh) |
IL (1) | IL108369A (zh) |
MX (1) | MX9400563A (zh) |
NO (1) | NO305166B1 (zh) |
NZ (1) | NZ261414A (zh) |
TW (1) | TW243445B (zh) |
WO (1) | WO1994017040A1 (zh) |
ZA (1) | ZA94317B (zh) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU662602B2 (en) * | 1992-02-06 | 1995-09-07 | Merrell Dow Pharmaceuticals Inc. | Reversal of multi-drug resistance by triphenyl-azacycloalkane derivatives |
AU6366000A (en) * | 1999-07-23 | 2001-02-13 | Colorado State University Research Foundation | Multidrug resistance pump inhibitors and uses thereof |
US6693099B2 (en) | 2000-10-17 | 2004-02-17 | The Procter & Gamble Company | Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance |
AU2002363523A1 (en) * | 2001-11-07 | 2003-05-19 | Pharmacia Corporation | Methods of promoting uptake and nuclear accumulation of polyamides in eukaryotic cells |
KR100656490B1 (ko) | 2001-11-26 | 2006-12-12 | 삼성에스디아이 주식회사 | 풀칼라 유기전계 발광표시소자 및 그의 제조방법 |
US8153184B2 (en) * | 2001-11-26 | 2012-04-10 | Samsung Mobile Display Co., Ltd. | Organic EL display device and method of manufacturing the same |
ES2936634T3 (es) | 2013-02-08 | 2023-03-21 | Gen Mills Inc | Productos alimenticios reducidos en sodio |
CN110372571B (zh) * | 2018-04-12 | 2022-11-15 | 中国科学院大连化学物理研究所 | 一种2-(2,2-二芳基乙基)-环胺衍生物或盐及合成和应用与组合物 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1049377B (de) * | 1952-04-03 | 1959-01-29 | Abbott Laboratories, North Chicago, 111. (V. St. A.) | Verfahren zur Herstellung von substituierten Vinylpiperidinen |
US2898339A (en) * | 1957-07-29 | 1959-08-04 | Wm S Merrell Co | N-substituted benzhydrol, benzhydryl, and benzhydrylidene piperidine |
US3956296A (en) * | 1974-12-11 | 1976-05-11 | A. H. Robins Company, Incorporated | 1-Substituted-4-benzylpiperidines |
US4035372A (en) * | 1976-08-13 | 1977-07-12 | G. D. Searle & Co. | 4-{[4-(Diphenylmethyl)-1-piperidinyl]methyl}benzenamines |
EP0235463A3 (en) * | 1985-12-20 | 1990-01-17 | A.H. ROBINS COMPANY, INCORPORATED (a Delaware corporation) | N-substituted-arylalkyl and arylalkylene piperidines as cardiovascular antihistaminic and antisecretory agents |
US4851423A (en) * | 1986-12-10 | 1989-07-25 | Schering Corporation | Pharmaceutically active compounds |
US4990511A (en) * | 1988-08-03 | 1991-02-05 | Takeda Chemical Industries, Ltd. | Amide compounds, their production and use |
WO1990015599A1 (en) * | 1989-06-19 | 1990-12-27 | The Wellcome Foundation Limited | Medicaments useful in cancer therapy and having antihistaminic properties |
GB9000305D0 (en) * | 1990-01-06 | 1990-03-07 | Pfizer Ltd | Anticholinergic agents |
EP0467435A3 (en) * | 1990-07-19 | 1992-04-01 | Akzo N.V. | Benzhydryl derivatives having calmodulin inhibitor properties |
ES2112268T3 (es) * | 1990-08-14 | 1998-04-01 | Hoechst Marion Roussel Inc | Nuevos 19-nor-esteroides que tienen en posicion 11beta una cadena carbonada que comprende una funcion amida, su preparacion, su aplicacion como medicamentos y composiciones farmaceuticas que los contienen. |
AU662602B2 (en) * | 1992-02-06 | 1995-09-07 | Merrell Dow Pharmaceuticals Inc. | Reversal of multi-drug resistance by triphenyl-azacycloalkane derivatives |
-
1993
- 1993-12-17 DE DE69309310T patent/DE69309310T2/de not_active Expired - Fee Related
- 1993-12-17 US US08/481,538 patent/US5648365A/en not_active Expired - Fee Related
- 1993-12-17 KR KR1019950702950A patent/KR100377280B1/ko not_active IP Right Cessation
- 1993-12-17 AT AT94906446T patent/ATE150748T1/de not_active IP Right Cessation
- 1993-12-17 NZ NZ261414A patent/NZ261414A/en unknown
- 1993-12-17 AU AU60148/94A patent/AU679723B2/en not_active Ceased
- 1993-12-17 JP JP51701194A patent/JP3398748B2/ja not_active Expired - Fee Related
- 1993-12-17 CA CA002152794A patent/CA2152794C/en not_active Expired - Fee Related
- 1993-12-17 HU HU9502195A patent/HUT72078A/hu unknown
- 1993-12-17 WO PCT/US1993/012300 patent/WO1994017040A1/en active IP Right Grant
- 1993-12-17 ES ES94906446T patent/ES2102830T3/es not_active Expired - Lifetime
- 1993-12-17 EP EP94906446A patent/EP0680470B1/en not_active Expired - Lifetime
- 1993-12-17 DK DK94906446.3T patent/DK0680470T3/da active
-
1994
- 1994-01-17 ZA ZA94317A patent/ZA94317B/xx unknown
- 1994-01-18 TW TW083100396A patent/TW243445B/zh active
- 1994-01-19 IL IL10836994A patent/IL108369A/en not_active IP Right Cessation
- 1994-01-20 MX MX9400563A patent/MX9400563A/es not_active IP Right Cessation
-
1995
- 1995-07-20 NO NO952885A patent/NO305166B1/no not_active IP Right Cessation
- 1995-07-20 FI FI953506A patent/FI112474B/fi active
-
1997
- 1997-04-21 GR GR970400848T patent/GR3023188T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
JP3398748B2 (ja) | 2003-04-21 |
DK0680470T3 (zh) | 1997-04-28 |
FI112474B (fi) | 2003-12-15 |
NO305166B1 (no) | 1999-04-12 |
EP0680470B1 (en) | 1997-03-26 |
US5648365A (en) | 1997-07-15 |
DE69309310D1 (de) | 1997-04-30 |
NO952885L (no) | 1995-09-20 |
KR100377280B1 (ko) | 2003-07-18 |
ES2102830T3 (es) | 1997-08-01 |
FI953506A0 (fi) | 1995-07-20 |
NZ261414A (en) | 1997-06-24 |
KR960700230A (ko) | 1996-01-19 |
CA2152794C (en) | 1999-04-06 |
DE69309310T2 (de) | 1997-11-06 |
HU9502195D0 (en) | 1995-09-28 |
WO1994017040A1 (en) | 1994-08-04 |
CA2152794A1 (en) | 1994-08-04 |
NO952885D0 (no) | 1995-07-20 |
HUT72078A (en) | 1996-03-28 |
EP0680470A1 (en) | 1995-11-08 |
ATE150748T1 (de) | 1997-04-15 |
FI953506A (fi) | 1995-07-20 |
MX9400563A (es) | 1994-07-29 |
ZA94317B (en) | 1994-08-18 |
JPH08505870A (ja) | 1996-06-25 |
AU679723B2 (en) | 1997-07-10 |
GR3023188T3 (en) | 1997-07-30 |
AU6014894A (en) | 1994-08-15 |
TW243445B (zh) | 1995-03-21 |
IL108369A0 (en) | 1994-04-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EE200200220A (et) | Uudsed tsüklopropaanid kui CGRP antagonistid, neid ühendeid sisaldavad ravimid ja meetodid nende valmistamiseks | |
EP0680470B1 (en) | Diarylalkyl piperidines useful as multi-drug resistant tumor agents | |
US5665780A (en) | Reversal of multi-drug resistance by tetraarylethylenes | |
US4061746A (en) | Lactamimide inhibitors of gastrointestinal hypersecretion | |
UA57031C2 (uk) | Фармацевтична композиція та похідні 4-оксобутанової кислоти | |
EP0643693B1 (en) | Reversal of multi-drug resistance by triphenyl-piperidine derivatives | |
CA2176016A1 (en) | Antiarrhythmic benzodiazepines | |
US4616017A (en) | Aminohydroxypropoxy substituted aryl compounds | |
US5190957A (en) | Treatment of multi-drug resistant tumors with quinolyl-and isoquinolyloxazole-2-ones | |
US5670521A (en) | Reversal of multi-drug resistance by triphenyl-azacycloalkane derivatives | |
EP0428107B1 (en) | Use of quinolyl-and isoquinolyloxanole-2-ones for the production of a medicament for the treatment of multi-drug resistant tumors | |
NZ197273A (en) | 2-(phenylcarbamoyloxyamino)-5(phenyl or pyridyl)-3h-1,4-benzodiazepines | |
US4332810A (en) | N-(Substituted)-2,5-ethano-8-hydroxy (or methoxy)-1,2,3,4,5,6-hexahydro-3 (or 4)-benzazocine centrally-acting analgesics | |
AR013222A1 (es) | Derivados de 3-oxadiazolil-1,6-naftiridin-2(1h)-ona-5-sustituidos; compuestos intermedios utiles en la preparacion de dichos derivados; composiciones farmaceuticas que comprenden dichos derivados y medicamentos capaces de actuar sobre receptores de benzodiacepinas que incluyen dichos derivados. | |
AU759249B2 (en) | Barbituric acid derivative and preventive and therapeutic agent for bone and cartilage containing the same | |
IE904076A1 (en) | Treatment of multi-drug resistant tumors with¹pyridyloxazole-2-ones | |
JP2002138089A (ja) | ナフチリジン誘導体 | |
MXPA00009358A (en) | Barbituric acid derivative and preventive and therapeutic agent for bone and cartilage containing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
MM9K | Patent not in force due to non-payment of renewal fees |